HK1091500A1 - Process for producing antithrombin iii composition - Google Patents

Process for producing antithrombin iii composition

Info

Publication number
HK1091500A1
HK1091500A1 HK06112176.5A HK06112176A HK1091500A1 HK 1091500 A1 HK1091500 A1 HK 1091500A1 HK 06112176 A HK06112176 A HK 06112176A HK 1091500 A1 HK1091500 A1 HK 1091500A1
Authority
HK
Hong Kong
Prior art keywords
antithrombin iii
iii composition
producing
sugar chains
producing antithrombin
Prior art date
Application number
HK06112176.5A
Other languages
English (en)
Inventor
Tsuyoshi Yamada
Mitsuo Satoh
Yutaka Kanda
Kazuya Yamano
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Publication of HK1091500A1 publication Critical patent/HK1091500A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01068—Glycoprotein 6-alpha-L-fucosyltransferase (2.4.1.68), i.e. FUT8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01047—GDP-mannose 4,6-dehydratase (4.2.1.47), i.e. GMD
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y501/00—Racemaces and epimerases (5.1)
    • C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
    • C12Y501/03018—GDP-mannose 3,5-epimerase (5.1.3.18)
HK06112176.5A 2003-10-09 2006-11-06 Process for producing antithrombin iii composition HK1091500A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003350164 2003-10-09
PCT/JP2004/015324 WO2005035563A1 (ja) 2003-10-09 2004-10-08 アンチトロンビンⅲ組成物の製造方法

Publications (1)

Publication Number Publication Date
HK1091500A1 true HK1091500A1 (en) 2007-01-19

Family

ID=34431032

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06112176.5A HK1091500A1 (en) 2003-10-09 2006-11-06 Process for producing antithrombin iii composition

Country Status (10)

Country Link
EP (1) EP1676860B1 (ja)
JP (1) JP4263191B2 (ja)
KR (1) KR101017336B1 (ja)
CN (2) CN103993056A (ja)
AT (1) ATE554097T1 (ja)
AU (1) AU2004279741B2 (ja)
CA (1) CA2542035C (ja)
ES (1) ES2383371T3 (ja)
HK (1) HK1091500A1 (ja)
WO (1) WO2005035563A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099988A1 (ja) * 2006-02-28 2007-09-07 Kyowa Hakko Kogyo Co., Ltd. α-1,6-フコシルトランスフェラーゼ変異体とその用途
KR101778174B1 (ko) 2006-07-05 2017-09-13 카탈리스트 바이오사이언시즈, 인코포레이티드 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
CN101517074B (zh) * 2006-07-05 2013-07-03 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
KR101510778B1 (ko) † 2007-07-12 2015-04-10 상가모 바이오사이언스 인코포레이티드 알파 1,6 당전이효소(ｆｕｔ8) 유전자 발현을 비활성화시키기 위한 방법 및 조성물
JP5662149B2 (ja) 2008-08-13 2015-01-28 協和発酵キリン株式会社 遺伝子組換えプロテインｓ組成物
JP6151640B2 (ja) * 2011-06-29 2017-06-21 協和発酵キリン株式会社 たん白質の精製方法
US9127274B2 (en) * 2012-04-26 2015-09-08 Alnylam Pharmaceuticals, Inc. Serpinc1 iRNA compositions and methods of use thereof
CN104884952A (zh) 2012-12-28 2015-09-02 生化学工业株式会社 付之鲎试验的抗凝血酶iii用的前处理剂及前处理方法
WO2016075662A2 (en) * 2014-11-15 2016-05-19 Zumutor Biologics, Inc. Dna-binding domain, non-fucosylated and partially fucosylated proteins, and methods thereof
EP3278814B1 (en) * 2015-03-31 2021-08-18 Kyowa Kirin Co., Ltd. Therapeutic composition containing antithrombin gamma
JPWO2020166557A1 (ja) 2019-02-11 2021-12-16 協和キリン株式会社 妊娠高血圧腎症の治療方法
CN111109248A (zh) * 2019-12-24 2020-05-08 武汉博士德生物工程有限公司 一种杂交瘤细胞冻存液及96孔板冻存复苏方法
CN115247160B (zh) * 2022-07-28 2024-03-15 格进(杭州)生物技术有限责任公司 蛋白核心岩藻糖基化修饰的检测方法
CN117567597B (zh) * 2024-01-17 2024-03-22 成都艾科斯伦医疗科技有限公司 一种抗凝血酶Ⅲ及抗Xa活性检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
DE69736261T2 (de) * 1996-01-24 2007-06-06 Toyo Boseki K.K. Alpha-1-6-fucosyltransferasen
WO2002002793A1 (fr) 2000-07-05 2002-01-10 Japan As Represented By Secretary Of Osaka University Processus de production de glycoproteine
CA2785941C (en) * 2000-10-06 2017-01-10 Kyowa Hakko Kirin Co., Ltd. Antibody composition-producing cell
JPWO2003085107A1 (ja) * 2002-04-09 2005-08-11 協和醗酵工業株式会社 ゲノムが改変された細胞
EP1498490A4 (en) * 2002-04-09 2006-11-29 Kyowa Hakko Kogyo Kk PROCESS FOR PREPARING ANTIBODY COMPOSITION
JP2005058111A (ja) * 2003-08-14 2005-03-10 Univ Osaka 糖鎖修飾制御方法

Also Published As

Publication number Publication date
ATE554097T1 (de) 2012-05-15
KR101017336B1 (ko) 2011-02-28
JPWO2005035563A1 (ja) 2007-11-22
WO2005035563A1 (ja) 2005-04-21
ES2383371T9 (es) 2012-12-14
CN1890262A (zh) 2007-01-03
CA2542035A1 (en) 2005-04-21
JP4263191B2 (ja) 2009-05-13
KR20060125732A (ko) 2006-12-06
EP1676860B1 (en) 2012-04-18
EP1676860A4 (en) 2008-12-31
EP1676860A1 (en) 2006-07-05
AU2004279741B2 (en) 2010-03-11
CA2542035C (en) 2013-02-26
ES2383371T3 (es) 2012-06-20
CN1890262B (zh) 2015-01-28
CN103993056A (zh) 2014-08-20
AU2004279741A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
HK1091500A1 (en) Process for producing antithrombin iii composition
MX280092B (es) Proceso para producir un compuesto de 5 - hidroxi - 4 - tiometilpirazol.
PL2142394T3 (pl) Układ prowadzący dla ruchomej szyby okiennej pojazdu samochodowego
TW200621990A (en) Process for producing polysaccharide K5
EP2159219A3 (en) An improved process for the preparation of armodafinil
PL1561754T3 (pl) Sposób wytwarzania związków kompleksowych 1,2-diaminocykloheksan-platyna(II)
UA94914C2 (ru) Способ получения солей тиотропия
AU2003266516A1 (en) Resin compositions, composites made by using the same, and process for production thereof
MXPA03006322A (es) Procedimiento mejorado para la sintesis de carbapenem.
EP2161575A3 (en) Analysis for glucose products using pyridinylboronic acid
AU2002345758A1 (en) Renewable, carbohydrate based co2-philes
EG23439A (en) Olefins production process.
WO2007072496A3 (en) A process to prepare sucralose
EP2006378A4 (en) NOVEL BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE, GENE ENCODING TRANSFERASE AND PRODUCTION METHOD THEREOF
EP1939184A4 (en) 1,3-DIIODOHYDANTOIN COMPOUND AND PROCESS FOR PRODUCING THE SAME
WO2002016322A3 (en) Process for the preparation of 2-aminoethylpyridines
PL377274A1 (pl) Urządzenie wzmacniające dla filiery dostarczającej włókna zwłaszcza szklane
WO2005075490A3 (en) Synthesis of polysulfated uronic acid glycosides
MXPA05013604A (es) Procedimiento para preparar acilsulfamoilbenzamidas.
EP1669458A4 (en) PROCESS FOR PRODUCING 1,4-DIHYDOXY-2-NAPHTHOTIC ACID
IL166374A0 (en) Novel process for producing imidazoÄ1,2-bÜpyridazine derivative
EP1849794A4 (en) PROCESS FOR THE SYNTHESIS OF A 1,2-TRANS-GLYCOSIDE DERIVATIVE
EP1518856A4 (en) PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE
WO2005028362A3 (de) Verfahren zur reinigung von schwefelsäuren
WO2004060794A3 (en) Molecular sieve ssz-63